Attended meeting in Perth this morning with around 30 others and Matthew Lehman went through the Investor Presentation which was released to the market this morning.
Matthew spoke for about 70 minutes then took 20 minutes of questions and came across as conservatively confident.
Patient recruitment for CAN 004 should pick up from now with full enrolement still achievable by Q2 2014. He explained the significance of getting it 100% right and doctor and patients keen to be part of CAN 004.
Capital raising was mentioned but current costs of circa $5 million/Q should not vary greatly as manufacturing costs come down and with grants, interest and Saxonys cash injection may keep the wolf from the door a bit longer ( my opinion )
Approx 6 month timeframe from what I could gather from patient selection to chemo then cVac.
All in all I am glad I attended and more confident now I have a better understanding of the processes involved and we have the right people running our company
PS : Worth watching the video in the presentation link
- Forums
- ASX - By Stock
- IMM
- todays shareholder meeting in perth
todays shareholder meeting in perth
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
30.0¢ |
Change
-0.005(1.64%) |
Mkt cap ! $436.3M |
Open | High | Low | Value | Volume |
30.5¢ | 31.3¢ | 30.0¢ | $960.6K | 3.161M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 188729 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 46153 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 188729 | 0.300 |
12 | 236310 | 0.295 |
17 | 444259 | 0.290 |
8 | 1046339 | 0.285 |
9 | 253967 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 46153 | 2 |
0.315 | 83754 | 5 |
0.320 | 172037 | 5 |
0.325 | 239547 | 4 |
0.330 | 68045 | 5 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |